Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Search
Generic filters

About PBD Biotech

PBD Biotech has developed a phage-based diagnostic for tuberculosis - a powerful tool in the fight to eradicate this devastating disease.

Loading...

Management Team

The PBD Biotech international management team brings together expertise in diagnostics, clinical and veterinary science, disease management and policy.

Industry Awards

PBD Biotech and its diagnostic Actiphage have been recognised by the veterinary, dairy and farming industries with awards for innovation.

PBD Biotech Limited specialises in the use of novel phage-based technology for the detection of tuberculosis and related mycobacterial diseases in the fields of human and veterinary diagnostics.

The company has developed proprietary technology that can be used to detect the presence of mycobacteria such as: Mycobacterium tuberculosis (Human TB), second only to Covid as a fatal infectious disease; Mycobacterium (bovine TB) and Mycobacterium avium subsp. paratuberculosis (MAP; Johne’s disease), which are both significant causes of loss of profitability in the agricultural industry.

The company was co-founded in 2018, by: Prof. Cath Rees, Professor in Microbiology at the University of Nottingham and Chief Scientific Officer at PBD Biotech; Dr Ben Swift, Research Fellow in Antimicrobial Resistance, Royal Veterinary College and Director of Research and Development at PBD Biotech; together with serial entrepreneur Dr Berwyn Clarke.

The registered office is at Ingenuity Centre,University of Nottingham, UK with the administrative centre in Thurston, Suffolk UK.


Actiphage is industry recognised:

  • 2019 Royal Dairy Innovation Award, awarded by the Royal Association of British Dairy Farmers (RABDF)
  • Cream Award for Innovation 2020, organised by British Dairying to promote best practice and recognise some of the brightest and best businesses and people across the industry
  • Vet Record Innovation Award 2021, where Actiphage was described by head judge, Professor the Lord Trees, as “having the potential to be a game-changer in tackling bTB”

Related content

Loading...
Tom Kellner

PBD Biotech expands its North American operations

January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as Director of Operations in North America, to advise on regulatory affairs and provide technical and customer support.
Tom Kellner

PBD Biotech expands its North American operations

January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as...

Innovation is a key differentiator, PBD Biotech CEO to say at Invest Midlands

January 17, 2022
Innovation directed at an unmet market need can stimulate economic development if the value creation is kept within the local economy. The recent pandemic has shown the huge value of diagnostics and tuberculosis (TB), for which there are currently few...

Innovation is a key differentiator, PBD Biotech CEO to say at Invest Midlands

January 17, 2022
Innovation directed at an unmet market need can stimulate economic development if the value creation is kept within the local...
Jane Theaker, CEO, PBD Biotech (c) Chelsea Shoesmith Photography - square

Jane Theaker appointed as new CEO as PBD Biotech gears up for next phase of development

December 10, 2021
PBD Biotech, developers of a phage-based diagnostic for tuberculosis, is moving to the next stage of its development. It is appointing Jane Theaker, of precision medicine company Kinomica, as the new CEO and bringing Commercial Director, Jonnie Yewdall, into a...
Jane Theaker, CEO, PBD Biotech (c) Chelsea Shoesmith Photography - square

Jane Theaker appointed as new CEO as PBD Biotech gears up for next phase of development

December 10, 2021
PBD Biotech, developers of a phage-based diagnostic for tuberculosis, is moving to the next stage of its development. It is...
Jonnie Yewdall

Former dairy farmer joins PBD Biotech’s fight against bovine TB

May 26, 2021
Jonnie Yewdall, a former dairy farmer, has been appointed Commercial Director at PBD Biotech. The company recently gained funding to take its Actiphage® blood test for bovine TB (bTB) and Johne’s Disease through the validation required for international industry acceptance.
Jonnie Yewdall

Former dairy farmer joins PBD Biotech’s fight against bovine TB

May 26, 2021
Jonnie Yewdall, a former dairy farmer, has been appointed Commercial Director at PBD Biotech. The company recently gained funding to...
1 2 … 5 Next »

developers of phage-based diagnostics

Contact Us

PBD Biotech Ltd
Link House, Elm Farm Park,
Great Green, Thurston,
Suffolk IP31 3SH,
United Kingdom

Registered Company Address
Ingenuity Centre,
University of Nottingham,
Innovation Park, Triumph Rd,
Nottingham NG7 2TU,
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

Health Protection Scotland has launched a consultation on bovine tuberculosis diagnostic testing - but only the skin test? Why not the use of a blood test, pre-movement to keep Scotland OTF status by detecting early infection? @P_H_S_Official @BritishVets

Read More
PBD Biotech

Johne's Disease is a ticking time bomb in the dairy herd, now Actiphage provides a pre-breeding blood test to stop its transmission. We explain the relevance of new research that proves the link between mycobacteria in the blood and the development of TB

Read More
PBD Biotech

Delighted to be taking our Actiphage tuberculosis blood test to Zambia, in a collaborative project with @ZambartResearch, @LSHTM, @LeicResearch The aim is to test its sensitivity in a real world setting. #Tuberculosis #EndTB #InvestToEndTB

Read More